Background: Visual hallucinations occur in various neurological diseases, but are most prominent in Lewy body dementia, Parkinson's disease and schizophrenia. The lifetime prevalence of visual ...
Treatment of mild cognitive impairment with acetylcholinesterase inhibitors is ‘not associated with any benefit’ and brings an increased risk of side effects, according to a new analysis. In results ...
A patent from Centre National de la Recherche Scientifique (CNRS), McGill University and Sorbonne University discloses new acetylcholinesterase (AChE) inhibitors reported to be useful for the ...
The acetylcholinesterase inhibitors have produced excellent results in patients with Alzheimer’s disease or dementia. I have heard that a lot of people, particularly students preparing for exams, take ...
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine: http://journals.plos.org/plosmedicine/article?id=10.1371 ...
Most medicines for Alzheimer’s disease improve your symptoms rather than treat the disease itself. A type of drug that’s often prescribed soon after you’re diagnosed is called a cholinesterase ...
Our preliminary search found 3 articles. All 3 were not relevant to our objectives and related to Charles Bonnet Syndrome, Parkinson's disease and hypothetical modelling of visual hallucinations. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results